Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of I-0401 in tibial plateau fractures requiring grafting
2006-003688-30Phase 2Completed
- Sponsor
- Kuros Biosciences
- Start
- Dec 2006
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of KUR-111 in tibial plateau fracture (3 arms), sponsored by Kuros Biosciences. Started Dec 2006; status: completed.
02
Drugs
KUR-111
03
Conditions
tibial plateau fracture
Beyond the preview
Go deeper on 2006-003688-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003688-30.